☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Iovance
The US FDA Grants Accelerated Approval to Iovance’s Amtagvi (lifileucel) as a Treatment for Metastatic Melanoma (MM)
February 19, 2024
Insights+: Key Events of ASCO 2020 Virtual Annual Meeting #ASCO20
June 1, 2020
Load more...
Back to Home
